day at room temperature and for another 4–5 days after the
introduction of an additional amount of reagent (0.5 g of
NaBH4 and 1.01 ml of CF3CO2H). Excess of reagent was
decomposed with saturated aq. NaCl (50 ml) at 0 ЊC, and two
layers were separated. The THF layer was dried over Na2SO4
and evaporated under reduced pressure. A small part of the
residue (200 mg/5 ml) was subjected to HPLC (mobile phase
MeOH–H2O 9:1), which showed three peaks. A broad peak 1
(tR 3.73 min, 87 mg) remained unidentified; peak 2 (tR 5.07 min)
was identified as 4-(α--rhamnosyloxy)benzylamine 3 (101 mg,
50%; Rf 0.64, MeOH) and peak 3 (tR 5.59 min) was recognized
as N,N-bis[4-(α--rhamnosyloxy)benzyl]amine 4 (6.3 mg, 3%;
Rf 0.61, MeOH).
min; Rf 0.14 (CHCl3–MeOH 9:1), 9], 25% [tR 6.76 min; Rf 0.14
(CHCl3–MeOH 9:1), 10], 33% [tR 8.77 min; Rf 0.12 (CHCl3–
MeOH 9:1), 11] and 38% [tR 8.36 min; Rf 0.12 (CHCl3–MeOH
9:1), 12], yield respectively.
O-Propyl (E)-[4-(ꢀ-L-rhamnosyloxy)benzyl]thiocarbamate 9.
[α]D Ϫ18 (c 1); λmax(MeOH)/nm 205, 223, 245; νmax(CH2Cl2)/
cmϪ1 3400, 3100, 2900, 1600, 1500, 1400 and 1260; HREIMS
(m/z) 371.1413 [calc. for C17H25NO6S: 371.1402 (M)]; EIMS
(m/z) (%) 371 (Mϩ, 0.3), 353 (0.5), 311 (1), 225 (30), 183 (22),
1
147 (10), 129 (12), 122 (15), 107 (100) and 77 (25). H and 13C
NMR data in Tables 2 and 3.
O-Isopropyl (E)-[4-(ꢀ-L-rhamnosyloxy)benzyl]thiocarbamate
10. [α]D Ϫ18.88 (c 0.9); λmax(MeOH)/nm 203, 220 and 245;
νmax(CH2Cl2)/cmϪ1 3400, 3100, 1600, 1520 and 1240; HREIMS
(m/z) 371.1383 [calc. for C17H25NO6S: 371.1402 (M)]; EIMS
(m/z) (%) 371 (Mϩ, 10), 328 (4), 225 (40), 182 (100), 166 (6), 147
(13), 129 (15), 122 (22), 107 (75) and 77 (10). 1H and 13C NMR
data in Tables 2 and 3.
4-(ꢀ-L-Rhamnosyloxy)benzylamine 3. [α]D Ϫ33.75 (c 0.8);
λmax(MeOH)/nm 201, 222 and 265; νmax(CH2Cl2)/cmϪ1 3400,
3100, 2900, 1640–1580, 1510, 1230 and 1150; HRCIMS (m/z)
253.1072 (Calc. for C13H17O5: 253.1075, M Ϫ NH2); ESMS
(ϩve) (m/z) 253; EIMS m/z (%) 253 (0.5), 147 (22), 129 (24), 107
(100) and 77 (17); 1H and 13C NMR in Tables 1 and 3.
N,N-Bis[4-(ꢀ-L-rhamnosyloxy)benzyl]amine 4. [α]D Ϫ13.88
(c 1.6); λmax(MeOH)/nm 192, 224 and 270; νmax(CH2Cl2)/cmϪ1
3050, 2950, 1630, 1580 and 1260; ESMS (ϩve) (m/z) 522
(Mϩ ϩ 1); EIMS m/z (%) 485 (0.5), 269 (0.5), 253 (1), 239 (5),
O-Butyl (E)-[4-(ꢀ-L-rhamnosyloxy)benzyl]thiocarbamate 11.
[α]D Ϫ47 (c 1); λmax(MeOH)/nm 201, 220, 245; νmax(CH2Cl2)/
cmϪ1 3400, 3100, 1620, 1500, 1230; HREIMS (m/z) 385.1549
[calc. for C18H27NO6S: 385.1559 (M)]; EIMS (m/z) (%) 385 (Mϩ,
15), 329 (1), 239 (75), 183 (85), 166 (17), 147 (19), 129 (26), 122
(30), 107 (100) and 77 (13). 1H and 13C NMR in Tables 2 and 3.
1
211 (6), 147 (22), 133 (24), 129 (25) and 107 (100); H and 13C
NMR in Tables 1 and 3.
N-Acetyl-4-[(2Ј,3Ј,4Ј-tri-O-acetyl)-ꢀ-L-rhamnosyloxy]-
benzylamine 5
O-Isobutyl (E)-[4-(ꢀ-L-rhamnosyloxy)benzyl]thiocarbamate
12. [α]D Ϫ40 (c 1); λmax(MeOH)/nm 205, 223 and 245;
νmax(CH2Cl2)/nm 3400, 3100, 2900, 1620, 1510, 1420 and 1240;
HREIMS (m/z) 385.1565 [calc. for C18H27NO6S: 385.1559
(M)]; EIMS (m/z) (%) 385 (Mϩ, 7), 329 (12), 239 (18), 183 (100),
To a solution of 3 (25 mg) in pyridine (0.5 ml) was added acetic
anhydride (0.5 ml) and the mixture was kept at room temper-
ature overnight. Usual work-up gave pure acetyl derivative 5 as
a white solid, mp 152–153 ЊC; Rf 0.52 (CHCl3–MeOH 9:1);
[α]D Ϫ25 (c 1.2); λmax(MeOH)/nm 224, 271; νmax(CH2Cl2)/cmϪ1
3100, 2950, 1740, 1660, 1600, 1510, 1420, 1380, 1260 and 1230;
HRCIMS (m/z) 438.1768 [calc. for C21H28NO9: 438.1764
(M ϩ 1)]; ESMS (ϩve) (m/z) (%) 438 (Mϩ ϩ 1, 100), 396 (20),
379 (5), 273 (95), 231 (10), 213 (25), 153 (7) and 107 (4); 1H and
13C NMR data in Tables 1 and 3.
1
147 (28), 129 (27), 122 (15), 107 (75) and 77 (7). H and 13C
NMR data in Tables 2 and 3.
Acknowledgements
We are grateful to the United States Education Foundation in
Pakistan for awarding a Fulbright Scholarship to Dr Rubeena
Saleem for the pursuit of this work in Cornell University.
4-(ꢀ-L-Rhamnosyloxy)benzyl isothiocyanate 6
References
A solution of 4-(α--rhamnosyloxy)benzylamine hydrochloride
(133 mg, 0.44 mmol) in H2O (5 ml) was placed in a three-neck
flask containing thiophosgene (33 µl, 0.44 mmol) in diethyl
ether (10 ml) at 0 ЊC under argon.13 To this reaction mixture
was added dropwise 2.7 M sodium hydroxide (5 ml) with con-
tinuous stirring. Stirring was continued for a further 5 min. The
two phases were then separated and the aqueous phase was
extracted twice with diethyl ether (30 ml). The combined
organic phase was evaporated under reduced pressure to give 6
as a yellow residue (72 mg, 53%).
1 S. Faizi, B. S. Siddiqui, R. Saleem, S. Siddiqui, K. Aftab and A. H.
Gilani, J. Chem. Soc., Perkin Trans. 1, 1992, 3237.
2 J. Dale, Stereochemistry and Conformational Analysis,
Universitetsforlaget, Oslo, 1978, p. 82.
3 A. H. Gilani, K. Aftab, A. Suria, S. Siddiqui, R. Saleem, B. S.
Siddiqui and S. Faizi, Phytother. Res., 1994, 8, 87.
4 A. H. Gilani, K. Aftab, F. Shaheen, B. S. Siddiqui, S. Siddiqui, R.
Saleem and S. Faizi, Proceedings of the conference on Natural Drugs
and Digestive Tract, ed. F. Capasso and N. Mascolo, EMSI, Roma,
1992, p. 179.
5 A. Murakami, Y. Kitazona, S. Jiwajinda, K. Koshimizu and
H. Ohigashi, Planta Med., 1998, 64, 319.
6 H. Sorensen, Phytochemistry, 1970, 9, 865.
General procedure for preparation of thiocarbamate glycosides
7 U. Eilert, B. Wolters and A. Nahrstedt, Planta Med., 1981, 42, 55.
8 J. Conchie and G. A. Levy, in Methods in Carbohydrate Chemistry,
ed. L. Whistler, M. L. Wolform and J. N. BeMiller, Academic Press,
New York, 1963, vol. II, p. 345.
9 N. B. Bashir, S. J. Phythian, A. J. Reason and S. M. Roberts,
J. Chem. Soc., Perkin Trans. 1, 1995, 2203.
4-(α--Rhamnosyloxy)benzyl isothiocyanate 6 (50 mg) was
refluxed with a freshly prepared sodium alkoxide (20 ml) for 30
min with continuous stirring. The reaction mixture was divided
between water (10 ml) and ethyl acetate (20 ml). The aqueous
phase was extracted thrice with ethyl acetate (30 ml). The com-
bined organic layer was washed with an equal amount of water
thrice, dried over CaCl2, and concentrated under reduced
pressure to give a crude product 7–12, which was further puri-
fied by HPLC. Mobile phase used for compounds 7, 10–12 was
MeOH–H2O (7:3) while that for glycosides 8 and 9 was
MeOH–H2O (1:1). HPLC of crude 7 gave pure niazinin A
(29%; tR 6.03 min); [α]D Ϫ35 (c 1). Compound 8 on HPLC
analysis gave niazimicin (22%; tR 15.27 min); [α]D Ϫ12 (c 1).
HPLC of 9–12 gave pure glycosidic analogues in 24% [tR 25.59
10 R. P. Iyer, L. R. Phillips and W. Egan, Synth. Commun., 1991, 21,
2053.
11 C. J. Pouchert and J. Behnke, The Aldrich Library of 13C and 1H FT
NMR Spectra, 1st edn., 1993, vol. 2, pp. 565 and 610.
12 F. M. Dayrit, A. D. Alcantar and I. Villasenor, Philipp. J. Sci., 1990,
119, 23.
13 A. Kjaer and K. Rubinstein, Acta Chem. Scand., 1954, 8, 598.
Paper a907050h
394
J. Chem. Soc., Perkin Trans. 1, 2000, 391–394